Liquid pharmaceutical composition

Details Liquid pharmaceutical composition Liquid pharmaceutical composition

2005-08-16

2005-08-16

Page, Thurman K. (Department: 1615)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C424S439000, C514S779000, C514S974000

Reexamination Certificate

active

06930119

ABSTRACT:
This invention relates to new pharmaceutical compositions and methods for their preparation, and in particular it relates to taste-masked liquid compositions comprising a solution of a histamine H2-antagonist complexed with an alginate and also containing a humectant. The solution is buffered to a pH of between about 6 to 7. The inventive solution may be flavored and sweetened and preserved.

REFERENCES:
patent: 3492131 (1970-01-01), Schlatter
patent: 4996222 (1991-02-01), Carlin et al.
patent: 5007790 (1991-04-01), Shell
patent: 5456918 (1995-10-01), Quirk et al.
patent: 5811123 (1998-09-01), Fuisz
patent: 5976578 (1999-11-01), Beyerle et al.
patent: 39 31 215 (1990-03-01), None
patent: WO 95 01780 (1995-01-01), None
patent: WO 95 01795 (1995-01-01), None
Washington N et al., “Effect of Alginate and Alginate-Cimetidine Combination Therapy on Stimulated Postprandial Gastro-Oesophageal Reflux.” Journal of Pharmacy and Pharmacology, London, GB, vol. 47, no. 11, pp. 879-882 (1995).

Affiliated with

Also associated with

Rating

Liquid pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3459911